Latrepirdine for Alzheimer’s Disease: Systematic Review (Cochrane Database of Systematic Reviews)

Summary

This systematic review investigated the potential of Latrepirdine as a disease-modifying intervention for Alzheimer’s Disease. The evidence suggests, so far, that Latrepirdine has no beneficial effect on cognition and / or function in patients.

The authors of this review pointed-out that their attempts at meta-analysis had been limited by the “small number of studies, imprecision, inconsistencies between studies and likelihood of bias”.

Full Text Link

Reference

Chau, S. Herrmann, N. [and] Ruthirakuhan, MT. [et al] (2015). Latrepirdine for Alzheimer’s disease. The Cochrane Database of Systematic Reviews, April 2015, Issue 4, No. CD009524. (Click here to view the PubMed abstract).

Advertisements

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Pharmacological Treatments, Quick Insights, Systematic Reviews and tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s